AMTECH SYSTEMS INC — Board/Management Information 2009

Jun 30, 2009

8-K 1 amtech_8k.htm CURRENT REPORT

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549

FORM 8-K

CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934

June 25, 2009 Date of Report (Date of earliest event reported)

Amtech Systems, Inc. (Exact name of registrant as specified in its charter)

Arizona	000-11412	86-0411215
(State or other
jurisdiction	(Commission	(IRS
Employer
of
incorporation)	File
Number)	Identification
No.)
131 South Clark Drive, Tempe, Arizona		85281
(Address of principal
executive offices)		(Zip
Code)

Registrant’s telephone number, including area code (480) 967-5146

Not applicable.
(Former name or former address, if changed since last
report.)

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions ( see General Instruction A.2. below):

o Written communications pursuant to Rule 425 under Securities Act (17 CFR 230.425)

o Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

o Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

o Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

Item 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers.

| (d)(1) | On June 25, 2009, the Board of
Directors of Amtech Systems, Inc. (the “Company”) elected Dr. Jeong Mo
Hwang as a Director of the Company. |
| --- | --- |
| (2) | There are no arrangements or
understandings between Dr. Hwang and any other persons pursuant to which
Dr. Hwang was selected as a Director. |
| (3) | Dr. Hwang has been appointed to
serve on the Company’s Technology Strategy Committee. |
| (4) | Dr. Hwang has not had any
transactions with the Company or its subsidiaries that are required to be
disclosed under Item 404(a) of Regulation S-K, nor have any such
transactions been proposed. |
| (5) | Dr. Hwang will receive an annual
retainer of $16,000 and fees of $1,800 per Board meeting attended in
person, $675 per Board meeting attended telephonically, $675 per
Technology Strategy Committee meeting attended in person and $450 per
Technology Strategy Committee meeting attended telephonically. Dr. Hwang
will receive $100 per hour for work performed by him at the request of and
to facilitate the purpose of the Technology Strategy Committee, and $50
per hour for travel time in connection with that work. In addition, under
the Company’s Non-Employee Directors Stock Option Plan, Dr. Hwang received a grant of options to purchase 6,000
shares of Common Stock upon election to the Board, and will receive an
annual grant of 5,000 shares of Common Stock, or such other number of
shares as maybe determined by the Board, upon each re-election to the
Board at the Company’s Annual Meeting of Shareholders. The exercise price
of the options is $5.01, the closing price of the Company’ Common Stock on
June 25, 2009. Each option has a term of ten years and is exercisable in
three equal installments commencing on the first anniversary of the date
of grant and continuing for the two successive anniversaries thereafter.
In the event of disability (as defined in the plan) or death of the
Director, all options will remain exercisable for a period of 30 days
following the date such person ceased to be a Director, or such other date
as may be determined by the Board, but only to the extent such options
were exercisable on the date the Director ceased to be a Director. |

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

/s/ Bradley C. Anderson
Name:	Bradley C.
Anderson
Title:	Vice
President and Chief Financial Officer